PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 21, 2023Clinical Infectious Diseases38 citationsOpen Access

Assessing the Diagnostic Performance of New Commercial Interferon-γ Release Assays forMycobacterium tuberculosisInfection: A Systematic Review and Meta-Analysis

View Full Paper
EOEdgar Ortíz‐BrizuelaLALika AprianiTMTania Mukherjee

Key Points

Key points are not available for this paper at this time.

Abstract

The QFT-Plus and the TB-IGRA have very similar sensitivity and specificity as WHO-approved IGRAs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ortíz‐Brizuela et al. (2023) studied this question.

synapsesocial.com/papers/69e789fcc8658f113bcb1919https://doi.org/10.1093/cid/ciad030
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical application of interferon gamma release assays for diagnosis of latent tuberculosis infection in children2010 · 2 citations
  2. 2Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study2021 · 28 citations
  3. 3Tuberculin skin test and Quantiferon test agreement and influencing factors in tuberculosis screening of healthcare workers: a systematic review and meta-analysis2015 · 32 citations
  4. 4[Concordance between the test of the tuberculin and Interferon Gamma Release Assay-IGRA in patients with immune-mediated inflammatory diseases].2019 · 5 citations
  5. 5Meta-analysis in clinical trials1986 · 39,978 citations